Recent news

World Blood Donor Day 2018

As part of World Blood Donor Day 2018, Cerba HealthCare is mobilizing for the second year in a row!

Give blood is a citizen and solidarity act that can treat, every year, 1 million patients.

Sensitive to this cause, from June 11 to 17, Cerba HealthCare participates in the operation #MissingType and hide the letters "A", "B" and "O" of its logo, corresponding to the letters of the blood groups.

Like us, join #MissingType, remove the letters "A", "B", "O" from your logos, mail signatures, social profiles (Facebook, Twitter, Instagram, Pinterest ...) and make the buzz by posting your initiatives on the internet with the hashtag #MissingType!

WE C_UNT _N Y_U !

Cerba announced today that the acquisition of Bio IDF Santé ("BIO 7") has been completed

Cerba announced today that the acquisition of Bio IDF Santé ("BIO 7") has been completed

€60.0 million senior notes due 2025 pricing

€60.0 million senior notes due 2025 pricing

Cerba HealthCare intends to offer €60.0 million in aggregate principal amount of its senior notes due 2025

Cerba HealthCare intends to offer €60.0 million in aggregate principal amount of its senior notes due 2025

Sale of Bio 7 to Cerba HealthCare

Exclusive agreement signed

New needle-free blood-sampling technology

Cerba  HealthCare  (Issy Les  Moulineaux – France)  and  Loop  Medical  (Lausanne – Switzerland) can now confirm their partnership following the  approval of a needle-free blood-sampling technology.

Ketterthill wins HR Manager of the Year award

Thursday, November 16, 2017, took place in Luxembourg, the HR On Gala, the unmissable event for professionals in human resources.

On this occasion, the award for "HR Manager of the year", the most coveted award of the evening, was awarded to Stephanie Simon, head of human resources at Laboratories Ketterthill.

The acquisition of Fleming Research strengthens the positions of Cerba HealthCare in Italia

Cerba HealthCare announces the consolidation of its Italian business, Cerba HealthCare Italia, through the acquisition of Fleming Research — a firm with a network of diagnostic centres based in northern Italy (Lombardy and Piedmont).

Cerba Healthcare, Medical Biology International Group, announces ...

Cerba Healthcare, Medical Biology International Group, announces the launch of its endowment funds, named Institut Cerba.

Cerba Healthcare and VitaDX sign a partnership to validate...

Cerba Healthcare and VitaDX sign a partnership to validate the VisioCyt® test for the early diagnosis of bladder cancer.